Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,008 public trials 572 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Phase I/II Study of hLL1 in Multiple Myeloma

NCT00421525

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Center for Cancer Care Goshen, Indiana, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Completed

Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma

NCT02992483

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • MD Anderson Cancer Center/University of Texas MD Anderson CC Houston, Texas, United States
  • Novartis Investigative Site Heidelberg, Victoria, Australia
  • Novartis Investigative Site Nantes, France
  • Novartis Investigative Site Heidelberg, Germany
View Trial Details
Completed

A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy

NCT01794507

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 117876 Tucson, Arizona, United States
  • Mayo Clinic /ID# 121495 Jacksonville, Florida, United States
  • Northwestern University Feinberg School of Medicine /ID# 117477 Chicago, Illinois, United States
  • University of Michigan Hospitals /ID# 80353 Ann Arbor, Michigan, United States
View Trial Details
Completed

Study Evaluating Venetoclax in Subjects With Hematological Malignancies

NCT02265731

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +30 more
Locations
  • NHO Nagoya Medical Center /ID# 129222 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 129061 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 129278 Nagoya, Aichi-ken, Japan
  • University of Fukui Hospital /ID# 165801 Yoshida-gun, Fukui, Japan
View all 14 locations
View Trial Details

Related conditions